retatrutide trial Reta clinical data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide vs. Tirzepatide: What's the

Because the peptide engages GIPR, GLP-1R, and GCGR within a single molecular scaffold, it is especially useful in experimental models designed to examine how receptor signaling, energy metabolism, and endocrine pathway regulation interact across tissues rather than in isolation

GLP-1 also slows down the rate at which the stomach empties, which helps control appetite and food intake

Most injectable GLP-1 medicationsincluding semaglutide (Wegovy) and tirzepatide (Zepbound)are given once a week

Explore these data and more at iHeardSTL

Understanding these differences helps you make informed decisions about whether to push for the maximum 12mg or find a comfortable maintenance dose at a lower level

Gaat het even niet